Thalidomide Shows Promise For Treatment Of Recurrent Ovarian Cancer

February 28th, 2008 | Category: Womens Health

Thalidomide, a drug blamed in the 1950s for causing birth defects, is now showing promise as a safe and effective treatment for women with recurrent ovarian cancer, according to a study led by a University of Minnesota Cancer Center researcher.Levi Downs, Jr.,

M.D., principal investigator for the multicenter, randomized Phase II clinical trial, has published the findings of that research study in the current issue of the journal Cancer.

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Cancer Vaccine Showing Promise In Ovarian Trials
  • Recurrent Low-Grade Carcinoma Of The Ovary Less Responsive To Chemo Than More Common Ovarian Cancers
  • European Medicines Agency Recommends The Approval Of Thalidomide For The Treatment Of Rare Bone-Marrow Cancer
  • Experimental Drug Boosts Survival In Recurrent Ovarian Cancer
  • Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L At University Of Pennsylvania

    • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.